BRCTF (BioArctic AB) Margin of Safety % (DCF Dividends Based): N/A (As of Jul. 05, 2026)


BRCTF BioArctic AB BRCTF
84 GF Score
Price $35.00
GF Value $50.52
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is BioArctic AB Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

BioArctic AB's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

BRCTF vs VRTX, REGN, ALNY: Margin of Safety % (DCF Dividends Based) Comparison

For the Biotechnology subindustry, BioArctic AB's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioArctic AB Margin of Safety % (DCF Dividends Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioArctic AB's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where BioArctic AB's Margin of Safety % (DCF Dividends Based) falls into.


BRCTF
84GF Score
BioArctic AB BRCTF
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BioArctic AB (BRCTF) Overvalued in 2026?

Based on GuruFocus' analysis, BioArctic AB stock appears to be undervalued. The current stock price of $35.00 is trading 30.7% below its estimated GF Value™ of $50.52. GuruFocus considers BioArctic AB to be Modestly Undervalued.

Key valuation signals for BRCTF:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: $50.52 vs. price of $35.00 (30.7% below fair value)
  • GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the BRCTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioArctic AB Business Description

Address Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
84GF Score

Get the complete analysis for BRCTF

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$35.00
Price
$50.52
GF Value